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Proteome is the complete set of proteins produced by the genome. It is much more 
complex than either the genome or the transcriptome. Moreover, protein products can 
not be accurately predicted from genome by decoding genomic sequences. As a result, 
proteomics, the large-scale study of the proteome is a growing research area in the 
post genomic era. The determination of the amino acid sequence of a protein is the 
first step toward the structure and the function of the protein and it is a crucial 
requirement for the success of proteomics. In this thesis we study two problems 
related to protein sequencing via mass spectrum. 
First, we discuss the protein post translational modifications (PTMs) identification 
via “top-down” mass spectrometry. In literature, database searching method is used to 
identify the modification. In this thesis, we propose a dynamic programming 
algorithm to solve this problem. Compared with the widely used database searching 
method, our new algorithm has several advantages. First, our method can work 
without a protein database. Second, there is no prior knowledge of the modification 
sites in the protein needed. Last but not the least, it can identify the modifications in 
polynomial time, which is very efficient compared to the widely used database 
searching method.  
Second, we discuss the de novo peptide sequencing problem. There are two kinds of 
algorithms to automate peptide sequencing in literature. One is the database searching 
method and another is de novo peptide sequencing. Scoring function is an important 
component for both methods. In literature, not a lot has been done to incorporate the 
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intensity pattern into the scoring function. We propose a new de novo peptide 
sequencing algorithm DTseq, which uses an intensity-based scoring function. The 
scoring function is based on two competing models. One of them is a decision tree 
probability model which fully explores the factors that influence the intensity pattern 
in the spectrum. The decision tree model estimates the likelihood of certain observed 
intensity given the local chemical and physical attributes of the fragment. Besides, a 
random probability model is used to estimate the probability that certain peak is 
actually a noise peak in the spectrum. To test our algorithm, we compare DTSeq with 
two best de novo peptide sequencing algorithms: Peaks and PepNovo. The results 
show that DTSeq performs best among all the three algorithms. It can obtain the 
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Chapter 1  
INTRODUCTION 
1.1 Motivation 
Human genomeI contains the complete set of genes required to build a functional 
human being. Nowadays, large quantities of deoxyribonucleic acid (DNA) have been 
sequenced, cataloged, and annotated. However, this information is not enough to infer 
biological function because the genome is only one source of information [8, 24]. The 
transcription of genes is the first stage of gene expression and is followed by the 
translation of messenger RNA to produce proteins. 
Proteome is the complete set of proteins produced by the genome. It is much more 
complex than either the genome or the transcriptomeII. Moreover, protein products 
can not be accurately predicted from genome by decoding genomic sequences. This is 
because each protein can be chemically modified in different ways after synthesis, 
which cannot be deduced from gene sequence. The modifications add chemical state 
to the basic protein sequence and cause the change in the protein function and cell 
signaling. In addition, the proteome is also very dynamic. It varies considerably in 
different circumstances due to different patterns of gene expression and different 
patterns of protein modification. As a result, proteomics, the large-scale study of the 
proteome is a growing research area in the post genomic era.  
                                                 
I The entire complement of genetic material in a chromosome set.  
II The full complement of activated genes, mRNAs, or transcripts in a particular tissue at a particular 
time. 
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A key requirement for the success of proteomics is the ability to identify 
unambiguous proteins in complex mixtures. The determination of the amino acid 
sequence of a protein is the first step toward the studying of the structure and the 
function of this protein. Moreover, some proteins will undergo a process called post-
translational modifications (PTMs). This process modifies some amino acids in a 
protein and changes its function. One well-known example is the methylation of 
histones. This process changes the function of histones and affects the formation of 
chromatin[12, 23, 40]. It in turn affects the gene regulation activity. Hence, it is 
important to have some methods to get the protein sequence and identify the post-
translational modification of a protein. Recently, mass spectrometry (MS) has 
become the method of choice for the rapid identification of proteins and the 
characterization of post-translational modification[34].  
1.2 FTMS and LC/MS/MS 
1.2.1 Fragmentation 
Generally in mass spectrometry experiments, proteins or peptides break along their 
backbones between successive amino acids during the stage of fragmentation. A 
protein P is a sequence of n amino acids, naaaP L21= , the single breakage along 
the protein’s backbone results in a prefix fragment (N-terminal fragment) 
and suffix fragment  (C-terminal fragment). Since the fragments retain a 
charge, they are also called the fragment ions and they can be detected by a mass 
spectrometer. 
iaaa L21
nii aaa L21 ++
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The fragmentation results are shown in the mass spectrum (Figure 1.1). The spectrum 
consists of many peaks, each of which is generated by many copies of one fragment 
ion. The position of the peak represents the mass/charge ratio of the corresponding 
fragment ion, and the height of the peak indicates the relative intensity of the 
fragment ion. As a result, different peptides/proteins usually produce different spectra. 
Then the task is to use the spectrum to determine its sequence or to identify the post-
translational modifications. This step is an indispensable process and many researches 
have been done to automate it. 
 
Figure 1.1: Mass spectrum 
1.2.2 FTMS 
There are two kinds of mass spectrometry used in the thesis. The first is the Fourier 
transform MS (FTMS)[33, 48]. This kind of spectrum is used to solve the top-down 
post-translational modification identification in proteins. To reach the goal, generally 
capture dissociation (ECD)[16, 42, 51] is used to cleave the whole protein. The most 
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important property of ECD is that it can cleave any amino acid bonds except for the 
N-terminal side of proline in the protein sequence. Through nonergodic dissociation, 
ECD induces much more general backbones and derives extensive sequence 
information without loss of posttranslational modifications from proteins. In general, 
ECD can cut about 50% of the amino acid bonds of a protein sequence. Figure 1.2 
illustrates the 5 possible types of fragment ions got from ECD and the most 
frequently appearing types of ions are the c-ion and z-ion. Fourier transform mass 
spectrum (FTMS) is then used to show the fragmentation result of the protein. FTMS 
has high precision in measuring mass/charge ratio. Another advantage of FTMS is 
that it can measure the masses larger than 10kDa.  
 
Figure 1.2: Fragment ions of ECD 
1.2.3 LC/MS/MS 
Another kind of spectrum is the LC/MS/MS spectrum which is used to solve the 
peptide sequencing problem in the thesis. In an MS/MS experiment, a mixture of 
proteins is first digested into peptides by enzymes such as trypsin and the masses of 




                    || 
----CHR----C----- NH------ CHR----
b = c - 17.03 
a = b - 26.99 
y = z + 16.02 
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sample. Trypsin only cuts the amino acid bonds C-terminal to Lysine (K) or Arginine 
(R). Then a different procedure called tandem mass spectrometry is used to test the 
unknown peptide in the spectrum. In this step, the charged peptides are fragmented 
and ionized by methods such as collision induced dissociation (CID). During the CID 
process, peptide bonds are broken and one peptide is divided into two fragments. 
Fragments retaining the ionizing charge after CID have their mass/charge ratio 
measured by the mass spectrometer. There are usually six types of fragment ions 
(Figure 1.3) got by a single cleavage along the peptide’s backbone directly. Among 
them, the b-ion and y-ion are the most frequently appeared ions in the spectrum. 
Besides, by some neutral losses (chemical group such as  and ), , 
, and are produced. However, these types of ions are 
much less observed than the b-ion and y-ion.  
 
                                        Figure 1.3: Fragment ions of CID 
OH 2 3NH OHb 2−
3NHb − OHy 2− 3NHy −
b = c - 17 a b c
1.3 Organization of the thesis 
In this thesis, we consider two problems related to protein sequencing. In the first 
problem, we propose a dynamic programming algorithm to identify the post 
a = b - 28
y = z + 17
x = y + 26




translational modifications (PTMs) with a “top-down” strategy using FTMS. In the 
second problem, we propose a new probability model which fully considers the 
chemical and physical factors that influence the intensity pattern for de novo peptide 
sequencing algorithm via LC/MS/MS spectrum. The rest of the thesis is organized as 
follows: In Chapter 2, we introduce the protein post translational modifications 
(PTMs) problem; In Chapter 3, we introduce the peptide sequencing problem; Then 













PTMs  IDENTIFICATION BY TOP DOWN MASS 
SPECTROMETRY 
2.1 Related Work 
Generally, there are two classes of methods for locating post-translational 
modification. The first approach is based on the bottom-up spectrum[14, 49]. In this 
case, protein is first digested into a collection of peptides with about 10 amino acid 
residues. Then their peptide masses got from the experiment are matched against the 
list of peptide masses expected from the protein sequence. The non-matching masses 
could imply the post-translational modifications. Those peptides are further 
fragmented to generate the “tandem mass spectrum” which is then used to identify the 
peptide and localize its modification. Normally, peptides are identified by matching 
the experimental spectrum against the theoretical spectra corresponding to the 
peptides in a database. There are several different algorithms, such as Peptide 
Sequence Tag[32], Sequest[10], and Mascot[35]. Sequence Tag searches peptides in 
the database by allowing partial peptide mass unmatched. The latter two, which were 
originally used to identify unmodified peptides, can be used to identify modification 
by taking more than one possible amino acid molecular weight into account, 
depending on the modification considered[5, 30]. However, such approaches generate 
more answers and the modified peptides identified are less certain. Another algorithm 
is based on de novo peptide sequencing[37]. It uses a new notion of spectral 
similarity that allows one to identify related spectra considering the multiple 
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modifications. But the results show that this method is not successful due to the 
limitation of de novo sequencing. 
Although the bottom-up approach is widely used, it may miss some modifications 
since the coverage of peptide fragments got from the digestion is not 100%. Even 
worst, the bottom-up approach becomes more unreliable when we study large protein. 
When the protein size is big, the number of fragments increases. The common 
spurious peptide mass can be mistaken to be a modified peptide mass. In contrast, 
these problems can be solved by using top-down spectrum [39, 43, 46]. 
In top-down protein sequencing, instead of digesting the modified protein into 
peptides, the modified protein is analyzed directly by ECD-FTMS, theoretically 
allowing the entire sequence available for examination and giving a more complete 
characterization of the protein and the associated post-translational modifications.  
After the spectrum is constructed, some algorithms can be applied to identify the 
modification. The only previous work is by Pesavento et al. and they suggested 
identifying modifications using database-searching approach [36]. They first 
construct a protein database that contains the intact proteins with different 
combinations of modifications. However, there are exponential possible combinations 
of modifications. To reduce the database size, the included modifications need to 
satisfy some prior biology knowledge. Then, the database is searched to identify a 
modified protein that best matches the spectrum. 
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The limitation of the database-searching algorithm is that it is based on the prior 
knowledge of PTMs sites. If modifications occur at some unknown sites, their 
method may not work.  
Thus we propose a new way to solve the problem. the contributions of our algorithm 
are as follows: 
1. In the database searching method, first all possible modified protein forms are 
listed in the database. When the protein size and the number of possible 
modifications increase, the number of possible modified protein forms grows 
exponentially. By dynamic programming, our method can localize the 
modification sites and determine the modification types in polynomial time. 
2. The modification can be identified without any prior knowledge about PTMs 
sites. In database searching method putative modification sites are needed 
based on prior knowledge. Thus by using our method novel modification sites 
can be discovered. 
The rest of this chapter is organized as follows: Section2 details the PTMs problem. 
Section3 gives a dynamic programming algorithm to solve the problem. Lastly, 
Section4 shows the experimental results. 
2.2 Problem Definition  
Let mH be the possible post-translational modified protein form of certain protein H 
and M  be the spectrum got by the fragmentation of the sample of modified H. We 
use all the fragment masses of mH  to match the peaks in M. Intuitively, the more 
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high intensity peaks are matched the more likely mH  is the correct post-translational 
modified protein for H that generates spectrum M. In this section we will give a clear 
picture of this problem.  
2.2.1 The Ion Mass Calculation 
Amino acids consist of 20 different types. We use Α to denote the alphabet of the 20 
amino acids. For any amino acid ∈a Α, wt(a) is denoted to be its monoisotopic mass. 
The maximum and the minimum masses among all amino acid types are 186.08 
Dalton and 57.02 Dalton respectively. 
Suppose there are t possible types of modifications for a certain protein. Including the 
non-modification case, there are t+1 types of modifications in total. We use ∑  to 
denote the alphabet of the t+1 types of modifications. For any ,   is 
denoted as the mass of this modification. The maximum modification mass is  
Dalton and the minimum modification mass is 0. 
∑∈m )(mwt
maxm
In total, the maximum and the minimum masses of a modified amino acid are 
186.08+ Dalton and 57.02 Dalton, respectively.  maxm
In the experiment, every fragment cleaved from mH  can have different charged 
states and generate a few different peaks in the spectrum. Fortunately, each isotopic 
cluster in the FTMS can be assigned a charge (e) based on the one Dalton inter-peak 
spacing (1/e) [17]. We can preprocess the FTMS spectrum and convert all peaks of 
different charged states into single charged equivalents. Furthermore, every isotopic 
cluster is represented by a peak at the monoisotopic mass. Its intensity is the sum of 
the intensities of all peaks in the corresponding isotopic clusters. Therefore, from now 
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on, every ion is assumed to be single charged and its peak is at its monoisotopic mass. 
In other word, a spectrum can be represented by ( ){ }numiyxM ii ≤≤= 1|, where 
num is the total number of peaks in M. Below, we describe the calculation of mass for 
every fragment ion of a protein. 
Consider a protein sequence H = . We denote  
Because of the extra H
naaaa K321 ∑ ≤≤= ni iawtHwt 1 )()( .
2O, the actual mass of H  is +18.01. )(Hwt
As shown in Figure 1.2, ECD fragments the protein H  into five different types of 
ions. The ions can be classified into two groups: the N-terminal group and the C-
terminal group. The N-terminal group contains a-ion, b-ion and c-ion while the C-
terminal group contains y-ion and z-ion. 
Consider the ith prefix of H , which is . Let iaaaa K321 x  be . Then, 
the corresponding masses of the a-ion, b-ion and c-ion in the N-terminal group are 
)( 321 iaaaawt K
x -
26.99, x , and x +17.03 respectively. We denote ( )xN  as: 
( )xN  = { x - 26.99, x , x  + 17.03} 
Similarly, for the ith suffix of niii aaaa K21 ++ H , let )( 21 niii aaaawtx K++=  be its 
mass. The corresponding masses of the y-ion and z-ion in the C-terminal group 
are x +18.01 and x + 1.99 respectively. We denote ( )xC  as: 
( )xC  = { x +18.01, x +1.99} 
Based on the above equations, ideally, the spectrum of the protein H should have a 
list of peaks whose masses are belonging to 
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( )HL  = ( ) ( )( )U KK11 2121 )()(−≤≤ ++∪ni niii aaawtCaaawtN                    (2.1) 
Now, H  is modified and let be the resultant modified protein 
where each  is the residue formed after  is modified by . Note that 
. Then,  can be defined similarly and the actual 
mass of 
n
m aaaH ''' 21 K=
ia' ia im
)()()'( iii mwtawtawt += )( mHwt
mH  equals +18.01. In addition, in the ideal case, the spectrum of 
the protein 
)( mHwt
mH should have a list of peaks whose masses are belonging to ( )mHL . 
Given a modified protein mH , after fragmentation, let ( ){ }numiyxM ii ≤≤= 1|, be 
the experimental corresponding FTMS spectrum of mH  with num peaks where, for 
the ith peak ,  is its mass (position) and is its intensity (height) in the 
spectrum.  
),( ii yx ix iy
Ideally, we expect M contains a list of peaks whose masses belong to ( )mHL . Since 
the experimental data is not accurate, the positions of the peaks may be shifted by a 
little bit. Let δ >0 be the error of the spectrometer. Due to the high accuracy of 
FTMS, we assume δ <0.5 in this chapter. For any peak ( )yx,  of M and ( )mHLw∈ , 
if δ≤− xw , we say that the peak ( )yx,  is explained by w. Denote ( )mHL  to be the 
set of all possible peaks in M that can be explained by some w in ( )mHL , that is: 
( ) ( ) ( ){ }.|, δ≤−∈∈= imiim xwthatsuchHLwisthereMyxHL             (2.2) 
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2.2.2 Modification Identification Problem 
mW  is the tested mass of the modified protein and the unmodified protein mass W 
can be calculated since we know the protein sequence. Based on the information we 
will try to determine the types and locations of modifications whose masses are 
summed up to - W.  mW
It is obviously that the more and higher peaks in M are explained by ( )mHL , the 
higher  chance that M is the spectrum generated by mH . In another word, the more 
and higher peaks in ( )mHL , the more likely mH  is the expected modified protein for 
H. Here, we use a simple function to evaluate the matching, that is, for any L  as a list 









                                                     (2.3) 
Note that the bigger the value )(LG , the more likely that mH  is the correct modified 
protein for H.  
The problem is summarized as follows: 
Consider a protein sequence H = , The mass of H is W = wt(H) + 18.01. 
Let  be the mass after H is modified and 
naaaa K321
mW δ  is the error bound of the mass 
spectrometer. We would like to compute the modified peptide  n
m aaaH ''' 21 K=
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such that (1) every  is the residue formed after  is modified by some ,  (2) 
 and (3) 
ia' ia im
δ≤−+ |01.18)(| mm WHwt ( )⎟⎠⎞⎜⎝⎛ mHLG  is maximized.  
For example, consider histone H4, its unmodified mass W is 11229.34 Dalton. 
Moreover, after modification, experiment shows that its mass  is 11243.36 Dalton. 
Hence, by calculation, the total modification mass ( - W)=14.02 Dalton. Then the 
modified histone samples are fragmented by ECD and produce the FTMS spectrum. 




K ) of H4 is methylated (the mass of methylation is 14.016 Dalton), 
which matches the ECD/FTMS best. Our founding matches with the known biology. 
2.3 Algorithm 
2.3.1 Dynamic Algorithm 
The purpose of our algorithm is to choose the best combination of modifications for 
the protein so that the number and the intensity of matched peaks of this modified 
protein are maximized. The difficulty is that we do not know the corresponding ion 
types of the peaks in the experimental spectrum and one peak could be matched by 
more than one fragment ions generated from the protein. We need to identify whether 
the peak has already been matched or not.  
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… … 
Fig 2.1 Complementary Pair 
Fortunately, the overlapping occurs only between the N-terminal ions of one prefix 
and the C-terminal ions of another suffix. All the N-terminal ion sets of prefixes do 
not overlap (the distance between two N-terminal ion sets is larger or equal to 57.02-
44.02). All the C-terminal ion sets of suffixes also do not overlap (the distance 
between two C-terminal ion sets is larger or equal to 57.02-16.02). Figure 2.1 shows 
the distribution of all the ions in a spectrum. The figure shows that the overlapping 
could occur between  and( )ksC ( )1+ipN  or between ( )knpN −  and .  Thus we 
can solve the overlapping problem by calculating the complement pairs from the 
outside to the middle gradually. That is to construct optimal prefixes and suffixes step 
by step together[29].  
( 1−−insC )
Let ( )xN  and ( )xC  denote the peaks matched by sets ( )xN and  in the 
spectrum. Besides we define  
( )xC
( ) ( ) ( ) ( ) ( ) ⎟⎠⎞⎜⎝⎛ ⎟⎠⎞⎜⎝⎛ −−∪⎟⎠⎞⎜⎝⎛ −−∪= yWNyCxWCxNGyxscore mm 01.18\01.18,      (2.4) 
… ……… 
( )1pN … ...C( )ipN ( )ks ( )1+ipN              ( )1−−insC ( )knpN − …C …C  ( )ins − ( )1−ns
…
)...( 21 jj aaawtp =  )...( 21 njnjnj aaawts +−+−= . 
)( jpN  andC  is a complementary pair  )( jns −
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( yxscore , )  is a simplified scoring function which sums up the intensities of all the 
peaks matched by the complement ion pairs of an x Dalton prefix excluding the peaks 
which are matched by another y Dalton suffix.  
Now let P be one prefix sequence and S be one suffix sequence in a modified protein. 
And max08.186|)(01.18)(| mPwtSwt +≤−+ . ( )SPL ,  denote the list of peaks which 
can be matched by ions corresponding to any prefix sequences of P (including P) and 
any suffix sequences of S(including S), 
When :  01.18)()( +< SwtPwt
( )( ) ( )( ) ( ) ( )( SwtPawtscoreSPLGSPaLG ,',,' += )                           (2.5) 
When  :01.18)()( +≥ SwtPwt
( )( ) ( )( ) ( ) ( )( )PwtWSawtWscoreSPLGSaPLG mm −−−−+= 01.18,'01.18,',     (2.6) 
Detail Algorithm: 
Based on the pervious part, it is obvious that by construction the modified sequence 
from both prefix and suffix we can solve the overlapping problem. In the following 
part we will describe the algorithm in detail. 
The protein sequence tested is  and . is the 
scoring function. As defined before,  
lenaaaa L321 DWW m =− ),( yxscore
∑  is the set of all the possible masses of 
modification types include 0 and Α is the set of the different masses of the 20 types of 
amino acids. 
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Let  be the total score for the first i amino acids and the last  j amino 
acids given that the total modification mass of the first i and last j amino acids equal 
to  and respectively. (
[ 21 ,,, qjqiT ]
1q 2q 1,0 −≤≤ lenji  and Dqq ≤≤ 21,0 ) 
[ 21 ,,, qjqiT ]  where max21 08.186 mqsqp ji +≤−−+  satisfies the following 
equations. 
Basis: 
[ ] 00,0,0,0 =T  
Recurrence:  
For 11 20,0,10,0 qDqqilenji −≤≤≥−−≤≤> we have the following recursive 
function: 
[ ]
[ ] ( )









































where  vWv m −= ; ; )...( 21 ii aaawtp = 01.18)...( 21 += +−+− njnjnj aaawts . The 






 Input: Total tested modification mass ; 
           A peak list of the spectrum; 
           Modification list ; 
           Sequence of the tested protein; 
           Mass of unmodified protein W by calculation; 




           Error bound δ of the spectrum; 
Output: the maximum scored modification allocations of modification masses D’ 
such that δ≤−DD' . 
1. Initialize all [ ] −∞=lkjiT ,,, ; Let [ ] 00,0,0,0 =T  
2. for i from 0 to len-1 step 1 do 
3.     for j from 0 to D  step ∆  do 
4.         for k from 0 to len-i-1 step 1 do 
5.            for l from 0 to D – j  if max08.186 mlsjp ki +≤−−+  step   do ∆
6.               if lsjp ki +<+                                                                        
                           for ∑∈m such that Dljmwt ≤++)(   
7.                         











                                 
8.              else    for ∑∈m such that Dljmwt ≤++)(   
9.               










                              
10. Compute the best  for all i, j, k, l and the [ lkjiT ,,, ] ∑∈m  satisfying 
1−−= kleni  and δ≤−++ Dmwtlj )(   
11.  Use backtracking to construct the best modification allocation 
 
Figure 2.2 PTMs Algorithm 












,min( DmlenlenO  time. 
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Proof. For any i,j,k,l such that [ ]lkjiT ,,, >0 and it is an optimal value, there is a 
prefix-suffix pair (  such that )SP, ( )Pwtjpi =+  and ( ) 01.18+=+ Swtlsk . Without 
loss of generality, assume that P’a = P and wt(P’) < wt(S)+18.01. Based on the 
above algorithm, there is some u such that [ ]lkuiT ,,,1−  corresponds to the 
pair . Line 8 shows that ( SP ,' ) [ ]lkuiT ,,,1−  must also be an optimal value if 
 is an optimal one. Thus [ lkjiT ,,, ] [ ]lkjiT ,,,  can be calculated from . 
The best modification allocation then can be got straightforwardly. 
[ ]lkuiT ,,,1−
Line 5 shows that only when max08.186 mlsjp ki +≤−−+ , the following part will 
be executed. Thus for the fixed i, j and l, there are at most 
02.57












DmlenlenO  elements in T need to be considered. 




δO  peaks in the spectrum can be explained by one mass 
















,min( DmlenlenO . 
In practice, there are still something can be done to improve the above algorithm. The 
following sections will introduce the several tips to accelerate the algorithm. 
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2.3.2 Change of Backtracking Algorithm 
As mentioned before, ECD normally breaks about 50% of the amino acid bonds of a 
protein, which means that there are still a lot of bonds not fragmented. However, 
cleaving the protein backbone between each modification site is critical to achieve 
complete modification identification and allocation[43]. If a lot of PTM sites are not 
broken from ECD, we cannot uniquely identify the locations of the PTM sites and 
many possible solutions can be generated. For example, consider a protein 
 and assume  is modified. Suppose ECD does not 
cleave at any site between  and . Since we have no knowledge on the amino 
acids between  and , a normal backtracking routine will report (k-i+1) possible 
solutions where the modification occurs at amino acid  for i≤x≤k. When there are 
more amino acids and more modifications occurring between  and , the possible 
cases will grow exponentially and it is inefficient to backtrack all possible solutions.  





To solve this problem we change the backtracking algorithm. Instead of tracing all 
the solutions, we just report that the modification occurs in a certain range. Using the 
above example, the modified backtracking algorithm will just output that there is a 
modification between  and . This is realized as follows: ia ka
Consider naaaH L21= and a spectrum M of the modified H. Let 




p −−−∪+= and ))01.18()((),( −+∪−−= qsCqsWNLqjL jjmS   
To help the modified backtracking, when we fill in the table T, we need to maintain 
the parent pointers using the following two steps. 
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1.  If  < ,  we set 1qpi + 2qs j +


















2.  If  , we set 1qpi + ≥ 2qs j +


















The above parent pointers ensure that we only trace back to [ ]21 ,,, qjqiT  entry where 
the mass  or  can be explained by some peaks in the spectrum. Our 
modified backtracking algorithm will trace back based on these parent pointers. Thus, 
we can avoid generating many solutions through backtracking and improve the 
efficiency. 
1qpi + 2qs j +
2.3.3 Change the Modification Mass Storing Method in the Table Element  
In the above algorithm, we only constraint that Dqq ≤+≤ 210  in . 
However, in most cases, only several modification mass values in the range from 0 to 
D are feasible. So, it is waste of space and time to construct and fill a table 
 for all  such that 
[ ]21 ,,, qjqiT
[ ]21 ,,, qjqiT 21 , qq Dqq ≤+≤ 210 . 
Thus we change the way to store modification mass values such that  and  only 
represent the meaningful value. We do this through the following steps: 
1q 2q
1. Construct a mass array E such that, for any mass m, E[m] = 1 if m is equal to 





DO  time. 
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2. Among all possible masses Dm ≤≤0 , let m1, m2, …, mn be masses such that 
E[mi]=1 and E[D-mi]=1. Let F be an array such that F[1]=m1, F[2]=m2, …, 
F[n]=mn. 
3. Now we can construct table [ ]21 ,,, qjqiT  with 1,0 21 −≤≤ nqq  and the 
modification masses can be got from  and . ][ 1qF ][ 2qF
For example, in histone, the possible modifications are methylation, phophorylation, 
ADP ribosylation, biotinylation and ubiquitination. So, the set of possible 
modification masses is {14.02, 42.01, 79.96, 541.06, 226.08, 8560.62}. If the total 
modification mass is 93.98 Dalton, we conclude that the only possible modification 
combination is methylation+phophorylation, which means that the possible values for 
 and  are either  93.98, 79.96, 14.02 or 0. If we use the original storing method, 
the table will have all the elements with  and  from 0 to 93.98. By using the new 
way to store modification masses, we have 
1q 2q
1q 2q
{ }98.93,96.79,02.14,0=F  and 4=n . 
Thus we can construct table [ ]21 ,,, qjqiT  with 3,0 21 ≤≤ qq . 
2.3.4 Scoring Function 
The scoring function we used is similar to which was stated in Bin Ma’s paper[26]. 
The difference is that in FTMS the most frequently appearing types of ions are c-ion 
and z-ion. Other types of ions are a, b and y.  
The main idea of the scoring function is that the more and higher peaks the ions of the 
sequence matches in the spectrum the higher score it will get. We choose c-ion and z-
ion as the main ions and other types of ions as the supporting ions.  
N-terminal ions: c, a and b, the main ion is c 
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                       ( ) ( ) ( ) ( )( )( ) hwwhhrhhruscon log/'exp// 221 ×−−××= δ                   (2.7) 
C-terminal ions: z and y, the main ion is z 
                               ( ) ( ) ( )( )( ) hwwhhruscoc log/'exp/ 21 ×−−×= δ                           (2.8) 
In the above formulas w is the theoretical mass of the main ion and w’ is the mass of 
the observed peak explained by w. In formula (2.7), u is a mass of prefix, w is the 
theoretical mass of u’s corresponding c-ion and w’ is the mass of the observed peak. 
While in formula (2.8) u is a mass of suffix, w and w’ are the theoretical mass and the 
observed mass of u’s corresponding z-ion respectively.  
In the formulas, h is the relative intensity of the peak corresponding to the main ion 
and   are the relative intensities of the peaks corresponding to the supporting 
ions. In formula (2.7), h is the relative intensity of c-ion and   are the relative 
intensities of a-ion and b-ion respectively. In formula (2.8), h is the relative intensity 
of z-ion and  is the relative intensity of the peak corresponding to y-ion. In the case 
when the main ion of the formula can not match any peak in the spectrum, we will 




In both formulas,  is a function whose value is always larger than one. It reflects 
the relationship between the main ions and supporting ions. When the ratio is in the 
reasonable range, the value of this function is big. On the other hand, when the ratio 
is too large or too small, the value of this function is small.  
( )xr
In total, we get the scoring function as follows: 
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( ) ( )xWscocxsconvxscore −+=),(                                    (2.9) 
Where x is a mass of prefix while v is a mass of suffix.  only considers the 
peaks which are matched by x’s corresponding ions but can not be explained by any 
corresponding ions of  v. This insures that the peaks in the spectrum will only be used 
once.  
),( vxscore
2.4 Experiment Result 
We use histones to test our algorithm. There are six types of modifications which can 
affect the amino acids in the histone sequences. They are methylation(14.02 Dalton), 
acetylation(42.01 Dalton), phophorylation(79.96 Dalton), ADP ribosylation(541.06 
Dalton), biotinylation(226.08 Dalton) and ubiquitination(8560.62 Dalton). Among 
them, methylation has three status, mino-, di-, or trimethylation.  Thus including zero 
there are 9 elements in .  ∑
To compare with the database searching method [36], we first construct an artificial 
data set which is similar to the experimental data stated in[36] to test our program. 
The tested histone is H4 with 112 Dalton above its unmodified mass and the known 
modification locations are positions 1, 16, and 20. Below figure graphically shows the 
modifications. 
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 Figure 2.3 A Modified Histone H4. The numbers above the sequence show the 
positions of the modified amino acids in the histone and the modification type is 
remarked below the sequence. 
In [36], the authors did an ECD/FTMS experiment on H4 and they reported all 
matched peaks in their webpage. We generate an artificial ECD/FTMS spectrum by 
randomly introducing 100% noise peaks into the spectrum. By the algorithm, we 
discover there is  an acetylation at N-terminal, an acetylation at position 16 and two 
methylations (or one di-methylation) at positions 20-21. The uncertainty at positions 
20-21 is because of the loss of important peaks resulted from the modification site. 
Below figure visualizes the modifications. 
 
Figure 2.4 The PTMs Result Got by Our Algorithm 
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To test the robustness of the algorithm, we gradually delete some matched peaks from 
the original spectrum. Table 2.1 shows the results. 
Deleted site i Modification allocation 
# of 
solutions  
# of solutions 
(original 
backtracking) 
19 N-terminal(Ac), 16(Ac), 19-21(2Me) 1 6 
19 to 18 N-terminal(Ac), 16(Ac), 18-21(2Me) 1 10 
19 to 17 N-terminal(Ac), 16(Ac), 17-21(2Me) 1 15 
19 to 16 N-terminal(Ac), 16-21(2Me+1Ac) 1 90 
19 to 15 N-terminal(Ac), 15-21(2Me+1Ac) 1 147 
Table 2.1. This table shows the modification allocation when we delete the peaks 
generated by the cleavage after ith amino acid from the spectrum. The 2nd last column 
shows the number of solutions reported by our algorithm. The final column shows the 
number of solutions reported if we use the original backtracking method. 
Table 2.1 shows that the algorithm can discover the modifications even when more 
important peaks are deleted. More importantly, our algorithm only report one solution. 
If we use the original backtracking method, many solutions are reported. Note that the 
number of solutions increases exponentially when more and more correct peaks are 
deleted. 
We should note that our algorithm does not require any prior knowledge of the 
modification site. If such knowledge is available, a better solution can be obtained. 
For example, in Figure 2.4, if we have the prior knowledge that V  could not be 
modified by methylation, we can conclude that the position 19 is not modified while 
position 20 is modified by a dimethylation. 
Besides, we got a real spectrum for histone H2A to test our algorithm. Based on the 
literature, the only known modification for H2A is acetylation and it occurs at the N-
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terminal. By running our program on the real spectrum, we report that there is an 
acetylation before the 6th amino acid. The following figure visualizes the result. 
 
Figure 2.5 The Modification Allocation of H2A 
We have investigated why the algorithm fails to find the exact location of the 
modification. After checking the spectrum, we found that the spectrum has no peak 
generated by the cleavage of the first five amino acids of H2A. 
However, there are several limitations of our method. First, the algorithm needs to 
know the set of modification types. We would like to explore if it is possible to detect 
PTM sites without knowing the modification types in advance. Second, the algorithm 
did not explore the intensity pattern of the FTMS such as the intensity relationship 
between different ions. We would like to utilize those intensity patterns to give a 
better scoring function to improve the performance of the algorithm. Finally, we hope 




                                                                
N-terminal, 
1-5




A DECISION - TREE PROBABILITY MODEL FOR DE 
NOVO PEPTIDE SEQUENCING 
3.1 Related work 
There are two classes of algorithms nowadays for solving the peptide sequencing 
problem. The first class is database searching method[1, 10, 35]. This approach is 
very popular and it can successfully identify some already-known proteins. The core 
of this approach contains three modules: (a) Interpret the tandem mass spectrum; (b) 
By using the interpreted spectrum and a protein database, some candidate peptides are 
identified; (c) Rank the candidate-peptides by a score function and output those high 
ranked peptides. Widely used algorithms such as Sequest[10] and Mascot[35] apply 
this approach. Although database search is a powerful tool for peptide identification, 
there are still some problems. A protein database is indispensable in this method and 
the peptides found by this method must already exist in the database. However, due to 
alternatively spliced genes, many peptides may not exist in the database [25]. Besides, 
because of the dynamic nature of peptides, database searching method may fail due to 
mutation and modification in the peptides.  
Because of the disadvantages of database searching method, a lot of researches have 
been focused on another class of algorithms, de novo peptide sequencing methods[2, 
4, 6, 13, 26-29, 32, 47]. De novo peptide sequencing problem is to derive the peptide 
sequence directly from the mass spectrum. Most popular algorithms use a spectrum 
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graph[4, 6, 26, 27] to solve the problem. A spectrum graph is formed by transforming 
the peaks in the tandem mass spectrum into an acyclic graph. Each peak in the 
spectrum is transformed to several vertices in the graph by assuming the peak is of 
different types of ions. Each edge in the graph links two vertices which are different 
by the mass of an amino acid. The de novo peptide sequencing problem is equivalent  
to finding the longest path in the spectrum graph. However, since every peak can be 
interpreted into several vertices, when a peak has a high intensity, there is a tendency 
that the longest path will include more than one vertex corresponding to the same 
peak. Although forbidding the simultaneous occurrences of pairs of nodes 
corresponding to the same peak can avoid the problem, when there are really different 
nodes corresponding to the same peak, this method will fail. Thus another algorithm 
Peaks[28, 29] is proposed which performs de novo peptide sequencing without using 
the spectrum graph. Peaks uses a dynamic programming to pick out the highest 
scored peptide from all possible peptides whose masses are equal or close to the 
experimental mass value. Basically, the algorithm gradually constructs optimal pairs 
of prefixes and suffixes in a carefully designated way, until the prefix and the suffix 
becomes long enough to form the optimal solution. 
For both de novo sequencing algorithms and database searching algorithms, the 
scoring function is critical to determine the accuracy of the methods. In general, there 
are two popular scoring functions. The first one is to correlate the experimental 
spectrum with the theoretical spectrum produced by candidate peptide[10]. 
Algorithms such as Sequest use this kind of scoring function. Another kind of scoring 
function uses probability value to evaluate the peaks in the experimental spectrum[1, 
6, 9, 15, 18]. Banfa and Edwards proposed a probabilistic model for database 
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searching method which considers the factors such as fragment ion probabilities and 
instrument measurement errors. Danick et al. designed a probability based scoring 
function for the de novo peptide sequencing algorithm, Sherenga[6]. However this 
scoring function does not fully exploit the factors that influence the intensities of the 
peaks in the spectrum. Since intensities are reproducible, some researches have 
focused on studying the chemical and physical properties of the peptides that will 
influence the intensity. Elias et al. used a probabilistic decision tree to model the 
probability of observing certain intensity for a given peak with certain particular 
chemical and physical properties. Then, they applied their intensity-based scoring 
function in database searching. Frank and Pevzner[15] proposed a scoring function 
using a probabilistic network which reflects the chemical and physical rules in 
peptide fragmentation. Then, they applied the score function in de novo peptide 
sequencing. 
In this thesis we proposes another way to use the probabilistic decision tree to model 
the peak’s intensity based on the chemical and physical properties of the fragment 
ions. Using our probabilistic decision tree model, we give an algorithm DTSeq that 
accurately solves the de novo peptide sequencing problem. Experimental results show 
that DTSeq has high accuracy. The rest of this chapter is organized as follows: 
Section 2 introduces some terminologies; Section 3 gives the scoring function and 




In this section, we will describe some basic terminologies and concepts. 
3.2.1 Amino acid property  
Amino acids are small biomolecules which are the principal building blocks of 
proteins. There are 20 common amino acids and we use Α to denote the alphabet of 
the 20 amino acids. In this chapter, each amino acid residue is characterized by four 
attributes: mass, gas-phase basicity, hydrophobicityIII  and helicityIV. (Table 3.1) The 
monoisotopic mass of each amino acid ∈a Α is denoted as wt(a). Note that 57.02 
Dalton ≤ wt(a) ≤ 186.08 Dalton. The gas-phase basicity[19] of an amino acid a is 
denoted as gb(a). It measures the tendency of a molecule to accept a proton in the 
reaction. Thus it is highly related to the proton affinity, which partially determines the 
site of proton attachment. A lot of evidence shows that the site of proton attachment 
influences the fragmentation reactions. Note that 202.7 ≤ gb(a) ≤ 237.0. 
Hydrophobicityand and helicity[7] of an amino acid a are denoted as hyd(a) and 
hlx(a), respectively. Hydrophobicity is an important factor to determine the protein 
stability while helicity is found to influence the folding of the nascent polypeptide 




                                                 
III Scaled from high-pressure liquid chromatography (HPLC) retention times 
IV Scaled from circular dichroism measurements of peptides in n-butanol 
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Amino 
Acid Mass Basicity Hydrophobicity Helicity 
A 71.0 206.4 0.16 1.24 
C 103.0 206.2 2.50 0.79 
D 115.0 208.6         -2.49 0.89 
E 129.0 215.6         -1.50 0.85 
F 147.1 212.1 5.00 1.26 
G 57.0 202.7         -3.31 1.15 
H 137.1 223.7         -4.63 0.97 
I 113.1 210.8 4.41 1.29 
K 128.1 221.8         -5.00 0.88 
L 113.1 209.6 4.76 1.28 
M 131.0 213.3 3.23 1.22 
N 114.0 212.8         -3.79 0.94 
P 97.1 214.4         -4.92 0.57 
Q 128.1 214.2         -2.76 0.96 
R 156.1 237.0         -2.77 0.95 
S 87.0 207.6         -2.85 1.00 
T 101.0 211.7         -1.08 1.09 
V 99.1 208.7 3.02 1.27 
W 186.1 216.1 4.88 1.07 
Y 163.1 213.1 2.00 1.11 
Table 3.1 Amino Acid Properties 
3.2.2 Fragment Ions 
Consider a peptide sequence constructed by n amino acids P = . We 
denote . Because of the extra H
naaaa K321
∑ ≤≤= ni iawtPwt 1 )()( 2O, the actual mass of P is 
+18 and we denote it as Ma(P). In the mass spectrometry experiment, the 
original whole peptide is charged by some H
)(Pwt
+ ions which is called the precursor ion. 
In this chapter we only consider the doubly charged peptide. Thus the peptide 
precursor mass is Ma(P)+2. 
As mentioned in Chapter 1, peptides are then fragmented into pieces during the 
Collision Induced Dissociation (CID) process. For instance, suppose a peptide 
 is fragmented into two parts by the cleavage between  and nii aaaaaP LL 121 += ia
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1+ia . Then,  is called the N-terminal amino acid to the cleavage site while  is 
called the C-terminal amino acid to the cleavage site. The fragments are charged and 
only charged pieces can be detected by mass spectrometer. The charged fragments are 
called fragment ions. After  a single cleavage along the peptide backbone, there are 
six possible types of fragment ions (Figure 1.3). Among them, the b-ion and y-ion are 
the most frequently appeared ions in the spectrum. Besides, by some neutral losses of 
chemical group such as  and , 
ia 1+ia
OH 2 3NH OHb 2− , 3NHb − , and 
are produced. These types of ions are much less observed than the b-ion and 
y-ion.   
OHy 2−
3NHy −
Based on the discussion above, the ions can be classified into two groups: the N-
terminal group and the C-terminal group. The N-terminal group contains b-ion, a-ion, 
c-ion,  and  while the C-terminal group contains y-ion, x-ion, z-ion, 
 and . Consider an amino acid sequence 
OHb 2− 3NHb −
OHy 2− 3NHy − kaaaH L21= , we define 
1)()( += HwtHB  while 19)()( += HwtHY , be the masses of H when H are  b-ion 
and a y-ion, respectively. 
3.2.3 Spectrum of a peptide 
The LC/MS/MS spectrum of a peptide consists of many peaks. Each peak is 
generated by a large amount of copies of some fragment ion of the peptide. As we 
have mentioned, the mass position of the peak in the spectrum represents the mass 
over charge ratio of the corresponding fragment ion, while the height of the peak 
indicates the intensity of the fragment ion.  
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However, mass spectrum usually contains many other peaks which are not produced 
by any fragment ions of the peptide. They could be the results of chemical 
contaminants and machine error. All these peaks are treated as noise. Besides, in our 
experiment, we only consider b-ion and y-ion in the spectrum since they are the most 
abundant ions. Because the limitation of our model, peaks corresponding to other 
types of ions are also treated as noise. The appearance of noise peaks adds difficulty 
to the de novo sequencing problem, since they may be considered as real peaks 
produced by false fragment ions. 
Given a peptide P, after fragmentation, let }1|),{( numiyxS ii ≤≤= be the 
corresponding spectrum which shows the fragmentations results of P. num is the 
number of peaks in the spectrum,  is the position (i.e. the mass over charge ratio) of 
the ith peak in the spectrum and  is the intensity value of the ith peak. Since the 
experimental data is not accurate, the positions of the peaks may be shifted by a little 
bit. We denote 
ix
iy
0>δ  be the measurement error of the experiments, which is assumed 
to be 0.5 in this chapter. To simply the discussion, when we say that there exists a 
peak in S at position w, we refers it to be the peak (xii, yii) where 
}||,),(|{argmax δ≤−∈= iiiii xwSyxyii . 
3.2.4 Factors which affect the abundance of a peak 
The intensity of a fragment ion depends on many factors during the low-energy 
collision induced dissociation process. To develop a robust intensity-based scoring 
method, it is important to understand the factors influencing the gas-phase 
fragmentation of peptides. 
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It is known that, in general, the peak of a y-ion has higher intensity than that of a b-
ion [20, 44]. Although y ions are only slightly more often appearing in the spectrum 
than b ions, their peaks are usually much more intense. Moreover, there are other 
factors. First, an abundant y-ion usually has an abundant complementary b-ion. 
Second, fragmentation near the N termini or C termini of the peptide causes low 
intensity peaks while fragmentation in the middle of the peptide causes much higher 
intensity peaks[44]. Tabb et al. have shown that the peaks of y-ion and b-ion are most 
intense around ~60% and ~45% of the precursor mass, respectively. Third, the 
intensity of a fragment ion is also influenced by its mass since the mass spectrum has 
certain observed scan range. Fourth, it is widely known that the intensity of a 
fragment ion depends on the type of the amino acids. For example, the fragmentation 
at the N-terminal side of proline produces low intensity peaks while the 
fragmentation at the C-terminal side of proline produces high intensity peaks[3]. 
Besides, based on the ‘mobile protone’ hypothesisV[41, 45], some other information 
such as peptide length, precursor charge state and the presence of basic residues also 
influence the fragment intensity[21, 41].  
3.2.5 Normalization and discretization 
The intensity of every peak in a spectrum may change due to different experimental 
environment. It is necessary to normalize the intensities of the peaks before we use it. 
In our case, we transform the intensities of the peaks into 4 discrete levels as follows. 
First, for every spectrum, we transformed the raw intensity ( ) of each peak into 
normalized intensity ( ) by the following formula. 
rI
nI
                                                 
V ‘mobile protone’ hypothesis:  the cleavage in a peptide is generally thought to be initiated by 





II =                                                           (3.1) 
where   is the average intensity of the one third of peaks in the spectrum which 
have the lowest intensities. Then, we discretize the normalized intensities of the peaks 
into 4 levels. The peaks with < 1 are included in Level 0. These peaks are treated as 
unobserved. For the remaining peaks, each of them is assigned to Level 1, 2, and 3, 
respectively, if , 
iI
nI
61 <≤ nI 166 <≤ nI  and .  16≥nI
Based on such normalization and discretization, for peaks corresponding to b-ion 
fragment or y-ion fragments, 15.5% of them are assigned to Level 1, 25.1% of them 
are assigned to Level 2 and 59.4% of them are assigned to Level 3. 
3.3 Score Function 
This section proposes an intensity-based scoring function that can be used to improve 
the accuracy of de novo peptide sequencing. The new scoring function is learnt from 
a training dataset of spectra and the corresponding peptide sequences. It is based on a 
probabilistic decision tree model which estimates the likelihood of observing certain 
intensity for a peak corresponding to a certain fragment ion. Below, we will first 
present the scoring function which is based on local peptide and fragment attributes. 
Then, given a training dataset of spectra and the corresponding peptide sequences, we 
describe how learn the probabilistic decision tree model from the training dataset. 
Finally, we will present the de novo peptide-sequencing algorithm based on such 
scoring function. Our algorithm is dynamic programming in nature and is similar to 
the one used in Peaks. 
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3.3.1 The likely scoring function 
Consider some spectrum S of peptide P. Let F be an fragment ion of the peptide P 
whose mass equals w. For I=0,1,2,3, the likely scoring function evaluates the 
likelihood of observing an intensity I for the peak at mass position w. Depending on 
whether F is b-ion or y-ion, the likely scoring functions or for b-ion or 



















Y =                                    (3.3) 
where Info(F) is the local information related to the fragment F (defined below), 
 and are the probabilities of observing an 
intensity I at mass position w given that F are b-ion and y-ion fragments respectively; 
 is the probability of observing an intensity I at mass position w 
by random. We estimate  and  using a decision 
tree and the detail will be discussed below.  estimates the 
probability that the peak is in fact some noise or is the peak of other fragment ion. It 
is computed based on the density estimation model in [15].  








A positive score for or  means the intensity is more likely to be 
produced by the candidate fragment ion while a negative score means that the peak is 
randomly matched and is unlikely to be produced by the fragment ion. Since the 
scores of the fragment ions of the peptide are independent, for a spectrum S and a 
)(Bsco )(Ysco
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peptide P=a1a2…an, the score score(P,S) for the peptide P can be computed by 
summing up the individual scores for all fragment ions of P as follows: Let  and 












∑= ;   and                       (3.4) 




iBnii KKKK ++ +=  
(3.5) 
Note that the bigger the score, the more likely that the spectrum S represents the 
peptide P. To complete the discussion, the remaining subsections will discuss how to 
compute the probabilities , , and 
. 




3.3.2 Computing and  using decision tree )),(|( SFInfoIprealB Y )),(|( SFInfoIpreal
Consider a fragment ion F of a peptide P. Suppose its mass is w. This section 
proposes to use probabilistic decision tree to learn how the properties of F affecting 
its intensity level. 
Based on previous discussion, the intensity of a fragment ion F may be affected by 
many local attributes of F, including (1) fragment ion mass, (2) intensity of the 
complementary fragment ion, and (3) the gas-phase basicity, hydrophobicity and 
helicity of the terminal amino acid to the cleavage site. Table 3.2 summarizes the set 
of attributes for describing F when F is a y-ion. When F is a b-ion, it can be described 
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by the same set of attributes in Table 3.2 except that the attribute “BionInt” is 




PosVI The position of the cleavage site along the peptide 
BionInt The intensity of b-ion 
Pmas Peptide precursor mass 
Mc Fragment mass/charge 
Masd Fragment mass minus peptide precursor mass 
Mcd Fragment mass/charge minus precursor mass/charge 
MdisnVII Mass distance from cleavage site to N-terminus 
MdiscVIII Mass distance from cleavage site to C-terminus 
Gbn Gas phase basicity of the N-terminal amino acid to fragmentation site 
Gbc Gas phase basicity of the C-terminal amino acid to fragmentation site 
Hlxn Helicity of the N-terminal amino acid to fragmentation site 
Hlxc Helicity of the C-terminal amino acid to fragmentation site 
Hydn Hydrophobicity of the N-terminal amino acid to fragmentation site 
Hydc Hydrophobicity of the C-terminal amino acid to fragmentation site 
Resn The N-terminal amino acid to fragmentation site 
Resc The C-terminal amino acid to fragmentation site 
Table 3.2 Training Attributes For Decision Tree 
Given the set of training peptides and their normalized spectra, then the probabilistic 
decision tree for y-ion can be generated as follows. First, from the training dataset, we 
generated all the y-ion fragment ions; for each y-ion fragment, a vector of its 
attributes and its intensity is generated to represent it. Then, the decision tree is 
trained using J4.8[27] based on the vectors. Furthermore, every leaf node of the 
decision trees is associated with a probability distribution of the 4 intensity levels. 
                                                 
Consider a peptide , the cleavage site between and  can creates the 
corresponding y-ion and b-ion.  









aaawtPos niii LL ++−==   
 
VII )()()( 2121 niii aaawtPwtaaawtMdisn LL ++−==  
VIII )()()( 2121 inii aaawtPwtaaawtMdisc LL −== ++  
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The probability of having intensity level I is estimated to be the proportion of the 
training fragment ions corresponding to this leaf node having intensity level equals I. 
By using a similar approach, we can get the probabilistic decision tree for b-ion. 
Figures 3.1 and 3.2 show the learned probabilistic decision trees for b-ion and y-ion 
fragments, respectively. Arrows pointing to the left indicate the fragments which 
satisfy the condition stated by the source node while arrows pointing to the right 
indicate fragments that do not. The histogram in every leaf node shows the intensity 
distribution of the peaks that assigned to it. The attribute in the root node shows the 
most important factor that will influence the fragment intensity. And the nodes closer 
to the root are more important. In the figures, the root node indicates that, in general, 
the fragmentation near the N-terminal (Pos≤ 0.14) produces low intensity peaks. This 
rule agrees with the known knowledge we have mentioned before. The decision tree 
also discovers other rules. For instance, the attributes of the N-terminal amino acid to 
the cleavage site have more influence on the fragment intensity and they appear in the 
decision tree while the attributes of the C-terminal amino acid to the cleavage site do 
not appear. Those identified rules prove the credibility of our method. In addition, it 
also increases our confident of the validity of the unknown rules discovered by the 
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As a matter of fact, though the decision trees for the b-ion and the y-ion (see Figure 
3.1 and 3.2) depend on many attributes, the values of those attributes can be 
computed based on the fragment mass of F (w=B(F) or Y(F)) and the N-terminal 
amino acid to the cleavage site (ai) only. In other word, Info(F) = {w, ai} is sufficient 
to compute  and .  )),(|( SFInfoIp Breal )),(|( SFInfoIp
Y
real
Given the decision tree in Figure 3.1 and a b-ion fragment F,  is 
computed as follows. First, we search the decision tree for b-ion and find a leaf node 
corresponding to F. Such leaf node is associated with a probability distribution. Then, 
 equals the probability for intensity I of such distribution. For a y-
ion fragment F, by applying the same procedure on the decision tree for y-ion (Figure 




3.3.3 Computing Random Probability  )),(|(random SFInfoIp
Consider a fragment ion F of mass w and a spectrum S. For I=0,1,2,3, this section 
would like to build a random probability model to compute , 
that is, the random chance that the peak in S at position w has an intensity I (that is, I 
is the highest intensity among the intensities of all the peaks in S within the range 
[
)),(|( SFInfoIprandom
δ−w .. δ+w ]). 
As the intensities of the peaks in the middle of the spectrum are much higher then the 
intensities in the two ends of the spectrum, we cannot assume the intensity of a noise 
peak follows a uniform distribution. Instead, we use the local density estimation 
model proposed by Frank and Pevzner. For completeness, we present their solution in 
this section. Consider a window of size u around w (the range from w-u/2 to w+u/2). 
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For i=1,2,3, Let  be the number of peaks in S whose intensity level is i within the 
size-u window. For a randomly chosen peak within the size-u window, the probability 
that the peak falls outside the range [
id
δ−w .. δ+w ] can be estimated as 
u
δγ 21−= . 






random SFInfoIp γ                         (3.6) 
The probability that the highest intensity level among all peaks within the range 
[ δ−w .. δ+w ] is as follows: 









The first factor  in the above equation calculates the probability there is at 
least one level-l peak within the range [
)1( ldγ−
δ−w .. δ+w ] while the other factor 
calculates the probability that all peaks that are in level higher than l fall outside the 
range [ δ−w .. δ+w ]. Thus the product of them is the probability that the highest 
peak is of level l.  
The above two equations imply that, in a dense region in S (region with many peaks), 
the probability is higher. This is reasonable since, in a dense 
region, it is more likely that the peak is matched by chance. Finally, note that 





Given a spectrum S and an observed peptide mass M, this section describes a dynamic 
programming algorithm to compute a peptide P, where  |M-18-wt(P)|≤δ, which 
maximizes score(P, S). 











                                                                                                                                   (3.8) 
Below lemma shows the usefulness of the table DT. 
Lemma: Suppose P=a1a2…an maximizes score(P,S). Then, for any 1≤i≤n, score(P, S) 
= DT[wt(a1a2…ai-1), wt(ai+1ai+2…an), ai].  In particular, there exists i such that 
 |wt (a1a2…ai-1) - wt(ai+1ai+2…an)-18| )1.186()(max iswhichawtaa Σ∈≤ . 






∑ . By definition of DT, 
score(P, S) = DT[wt(a1a2…ai-1), wt(ai+1ai+2…an), ai] for any 1≤i≤n. Since the weight 
of any amino acid is smaller than 186.1, there should exist i such that |wt(a1a2…ai-1) - 
wt(ai+1ai+2…an)| .                □ )1.186()(max iswhichawtaa Σ∈≤
Consider a b-ion fragment F of mass v. Suppose F  is the complementary y-ion 
fragment of F and the rightmost amino acid of F is a. Note that Info(F)={v,a} and 








vB +=             (3.9) 
if  and are not peaks at mass Y(v’) and B(M – v’ – 18), respectively. Otherwise, 






In the above formula,  equals ),',( avvscore ),( FFscore if and F F   but cannot be 
explained by Y(v’) and B(M – v’ – 18). This insures that the peaks in the spectrum 
will only be used once. 
Below recursive formula allows us to compute all entries DT[b,y,a], where 
 and b+y+wt(a)≤M-18+δ using dynamic programming. 1.186|| ≤− yb
Lemma: For and a∈Α, 1.186|| ≤− yb










 Basis: DT[0,0, a] = 0; 
Proof: Without loss of generality, we just prove case (1). DT[b, y-wt(a’), a’] 
corresponds to the score of a prefix-suffix pair ( ) such that , 
 and , 
', FF iaaaF L21=
)(Fwtb = njj aaaF L21' ++= )'()'( Fwtawty =− . Since 
and1.186|))'((| ≤−− awtyb bawty ≤− )'( , we have 1.186|| ≤− yb . Suppose 
, thus . From formula (1) and the definition of DT, the score '''' FaF = )''(Fwty =
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for a new prefix-suffix pair ( ) can be got, which is a candidate value for  DT[b, 
y, a]. Because DT[b, y-wt(a’), a’] and DT[b-wt(a’), y, a] are both optimal values, 
DT[b, y, a] thus must also be the optimal value for certain prefix-suffix pair.           □ 
'', FF
Note that . Hence, the target peptide P 
can be found as follows: First, we evaluate all entries DT[b,y,a], where 
 and |b+y+wt(a)+18-M|≤δ, based on the above recursive formula; Then, 
among all entries DT[b,y,a] such that |b+y+wt(a)+18-M|≤δ, we find the entry DT[b, y, 
a] with maximum value; Finally, by backtracking, we can recover the peptide P. The 
Pseudo Code is shown in Figure 3.3. 
],,[max),( |18)(| aybDTSPscore Mawtyb δ≤−+++=
1.186|| ≤− yb
Input: Observed peptide mass M; 
           A peak list of the spectrum S; 
           Error bound δ of the spectrum; 
           A calibration ∆ ; 
           Window size u for estimating the random hit probability. 
Output: A peptide such that its score is maximized and δ≤−+ |18)(| MPwt  
1. Initialize all [ ] −∞=ajiDT ,, ; Let [ ] 0,0,0 =aDT for all Α ∈a
2.   for i from 1 to  step )(max2/ awtM
aa ∑∈+ ∆  do 
3.   for j from  to )(max awti
aa ∑∈− )18),(maxmin( iMawti aa −−+ ∑∈ step  do ∆
4.       for  Α do ∈a
5.          if i < j 
6.             for  Α such that ∈'a 18)'( −<++ Mawtji do                                                                   










                                 
8.          else 
9.              if   18)( −<++ Mawtji   
     10.                 for  Α ∈'a










     12. Find the best  for all i, j, a satisfying[ ajiDT ,, ] δ≤−+++ Mawtji 18)(   
     13.  Use backtracking to construct the peptide sequence 
 
Figure 3.3 De Novo Algorithm 
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Lemma: In lines 7 and 11, the score() function can be computed in )(∆
uO  time 
Proof: The score() function is got by the sum of and )),(|( SFInfoIsco FB
)),(|( SFInfoIsco FY . As we have mentioned before, (or )),(|( SFInfoIsco FB
)),(|( SFInfoIsco FY ) is composed of two parts. The first part is 
( or )),(|( SFInfoIp F
B
real )),(|( SFInfoIp F
Y
real ) and this part can be calculated by 
going through the decision tree. There are at most )(∆
δO  peaks explained by a single 
fragment mass, thus this part can be computed in )(∆
δO  time. The second part is 
 (or )),(|( SFInfoIp Frandom )),(|( SFInfoIp Frandom ) and it is calculated by using a 
window u to calculate the local density. Because there are at most )(∆
uO  peaks in the 
window, the time complexity of  this part is )(∆
uO . Thus, in total, score() can be 
computed in )(∆
uO  time.                                                                                             □ 





Α∈ )(max awtuMO a  time. 
Proof: Since the scoring function can be calculated in )(∆
uO time, besides, based on 
line 2 and line 3, we can proof that the algorithm can compute the optimal solution of 





∑∈ )(max awtuMO aa  time.       □ 
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3.4 Experiment Result 
3.4.1 Data Set 
In Genome Institute of Singapore (GIS), we analyzed multiple Yeast Hormone 
protein sources using electrospray ion trap mass spectrometers and generated many 
MS/MS spectra. Then, a set of 1260 spectra of doubly charged tryptic peptides are 
selected, which were identified by Sequest with high score 
( and ).  These 1260 spectra are used as training set. Note that 
doubly charged tryptic peptides are selected since this class of peptides is the most 
common in mass spectrometry experiments. Besides, the fragment ion considered in 
the experiments are single charged b-ion and y-ion. This is because these two kinds of 
ions are most frequently appeared in the spectrum. 
0.2≥Xcorr 10.0≥∆Cn
For test set, we selected 400 spectra from Open Proteomics Database (OPD)[38]. 
These spectra were also identified by Sequest with high score (Xcorr > 2.5 and 
multiple hits). The peptides corresponding to these spectra contain 9 to 18 amino 
acids. The average length of these peptides is 13.7. 
3.4.2 Result 
Consider a predicted peptide from a particular de novo peptide sequencing algorithm. 
An amino acid of the predicted peptide is considered as correct if its mass position in 
the predicted sequence is within 1.5 Daltons from its expected mass position in the 




acidsinomapredictedcorrectofnumberaccuracy =                  (3.10) 
Besides, as the mass difference between amino acids Isoleucine (I) and Leucine (L) 
and between Lysine (K) and Glutamine (E) are smaller than 0.05 Daltons, we do not 
distinguish them in our accuracy measurement. 
To test the performance of our algorithm, we compare our algorithm DTSeq with 
Peaks and another de novo peptide sequencing algorithm PepNovo based on the 
above measurement. (To the knowledge of the authors, PepNovo and Peaks are the 
most accurate de novo peptide sequencing algorithms in the literature.) The 
experiment is as follows. For all three algorithms, we supplied the 400 test spectra to 
them and computed the predicted peptides sequences. Then, the average accuracies of 
the three different algorithms are measured. Table 3.3 shows the results. 
Algorithm Average Accuracy #Predicted Amino Acids 
DTSeq 0.689 11.6 
PepNovo 0.617 12.8 
Peaks 0.550 13.7 
Table 3.3 Average Accuracy of  Three Algorithms 
Since the cleavage sites in the center of the peptide produce much more stronger 
peaks, while the peaks of terminal parts are weak. Our algorithm can avoid predict 
the unconfident terminal amino acids to improve the accuracy.  
From Table 3.3, the accuracy of our method for the test set is highest among all the 
three algorithms. Note that both our method and PepNovo use intensity-based scoring 
function. Thus intensity-based scoring function seems to be able to improve the 
accuracy.  
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As de novo sequencing algorithms are often used to predict partial, rather than 
complete peptides.  The capability of the algorithms to reconstruct correct 
consecutive amino acids subsequences is very important. We also compared the 
maximal length of correct subsequence of each predicted peptide generated by all 
three algorithms. 
          Ratio of maximal correct subsequence length  Algorithm 
3≥  4≥  ≥ 5 ≥ 6 ≥ 7 ≥ 8 ≥ 9 ≥ 10 
DTSeq 0.94 0.87 0.75 0.63 0.51 0.42 0.32 0.21 
PepNovo 0.92 0.83 0.72 0.60 0.51 0.41 0.30 0.21 
Peaks 0.86 0.80 0.65 0.53 0.43 0.33 0.25 0.17 
Table 3.4 Proportions of Subsequence Length longer than l ( ) 103 ≤≤ l
Table 3.4 shows that the proportions of the predicted sequences which have a 
maximal correct subsequence length longer than l ( 103 ≤≤ l ).The result implies that 
the predictions made by intensity-based scoring methods are consistently having 
longer correct subsequences. 
Although the experiment shows that our method performed the best, there are still 
several limitations. First in our decision tree model for DTSeq, only b-ion and y-ion 
are considered. In the future, we may train more types of ions such as a-ion and some 
neutral losses ions. Second, our model could only be applied to double charged 
peptides, we may expand the model to include additional charge states. Third, our 
method is not fast enough to get the results, we will try to modify the algorithm and 
make it more efficient. Last but not the least, we plan to do more tests in the future to 






Protein sequencing is an important problem in the post-genome era. In this thesis, we 
studied two problems related to protein sequencing.  
The first is the protein post translational modifications identification problem. We 
proposed a dynamic programming algorithm via a “top-down” mass spectrometry to 
solve this problem. There are many advantages of this new method. First, our method 
can work without a protein database. Second, there is no prior knowledge of the 
modification sites in the protein needed. Last but not the least, it can identify the 
modifications in polynomial time, which is very efficient compared to the widely 
used database searching method. The experiment shows that our algorithm can get the 
correct results while much more efficient. 
The second is the de novo peptide sequencing problem. A lot of research has been 
done to solve the peptide sequencing problem. Generally there are two kinds of 
algorithms. One is the database searching method and another is de novo peptide 
sequencing. However, little work has been done to utilize the intensities of the peaks 
in the mass spectrum to improve the accuracy of the peptide sequencing. We 
proposed a decision tree probability model which fully explores the factors that 
influence the intensity pattern. The scoring function of this algorithm is based on two 
models. First we introduced a decision tree probability model which estimates the 
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likelihood of certain observed intensity. Unlike Elias et al.[9] decision tree, our 
decision tree can model the dependence between y-ion and b-ion. Moreover, to avoid 
high computational complexity, our decision tree only utilizes the local chemical and 
physical attributes of the fragment. Besides, a random probability model is used to 
estimate the likelihood that a certain peak is a noise. In the experiment, we compared 
DTSeq with two de novo peptide sequencing algorithms: Peaks and PepNovo. The 
results showed that DTSeq performed better than the other two algorithms. It 
obtained the longest maximum subsequence of predicted peptide as well as the 
highest prediction accuracy. 
4.2 Future Work 
The results obtained for both problems in the thesis demonstrate the advantage of our 
new algorithms. There are still several possibilities for future work. In our PTMs -
identification method, we would like to explore if it is possible to detect PTM sites 
without knowing the modification types in advance. In our decision tree model for 
DTSeq, only b-ion and y-ion are considered. In the future, we may train models for 
more types of ions such as a-ion and some neutral losses ions. Peptide of other charge 
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Mass spectrometry in proteomics is used in three major areas [31]. First it is usually 
used for protein identification. Second, because mass spectrometry is able to measure 
the molecular weight of a protein, it is a tool for detection and characterization of post 
translational modifications (PTMs) in protein. Finally, mass spectrometry is a good 
technique for characterization and quality control of recombinant proteins and other 
macromolecules. In this thesis we discuss the first two usages of mass spectrometry.  
A mass spectrometer has three components: a source of ions, a mass analyzer and a 
detector. The sample is first evaporated in a vacuum and exposed to a high voltage, 
converting the molecules into gas phase ions. The ions are then accelerated through a 
mass analyzer towards a detector. The mass analyzer separates the ions according to 
their mass/charge ratio. The detector records the impact of individual ions, producing 
peaks on a mass spectrum. The mass of a molecule can then be calculated from the 
mass/charge ratio of its derivative ions.  
Matrix-assisted laser desorption ionization (MALDI) and Electrospray (ES) are the 
two important ionization techniques that should be credited most for the success of 
mass spectrometry in the life sciences. During the MALDI process[22], a matrix 
material is first coprecipitated with the analyte molecules. The resulting solid is then 
irradiated by nanosecond laser pulses. The amount of energy imparted to the 
biomolecules by the matrices during desorption and ionization are different, which 
causes the different degree of fragmentation. The precise nature of the ionization 
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process in MALDI is still largely unknown and it is difficult to relate peptide peak 
height with the quantity of sample present unless an internal standard is used. Besides, 
the mass range below 500 Daltons is often obscured by matrix-related ions in MALDI.  
During the ES process[11], liquid containing the analyte is pumped at low microliter-
per-minute flow rates through a hypodermic needle at high voltage to electrostatically 
disperse, or electrospray, small, micrometer-sized droplets, which rapidly evaporate 
and which impart their charge onto the analyte molecules. There is no upper mass 
limit to the analysis by ES mass spectrometry. Because large mass ions are typically 
multiple charge. Thus they can be into the certain range of mass/charge ratio of the 
mass spectrometers. ES mass spectrometry can analyze very complex mixtures. But 
when the molecular weight and the number of molecules increases, the spectra 
become increasingly difficult to interpret. ES is generally performed in three situation:  
the infusion mode; the nanoelectrospray format and in combination with high-
performance liquid chromatography (HPLC).  
There are three different principles [31] applied to achieve mass separation: 
separation on the basis of time-of-flight (TOF MS); sepration by quadrupole electric 
fields generated by metal rods (quadrupole MS) or separation by selective ejection of 
ions from a three-dimensional trapping field (ion trap MS or Fourier transform MS). 
The same separation principle or different separation principles can be used twice to 
perform the two step mass spectrometry (MS/MS), which is used for structural 
analysis such as peptide sequencing. These three separation methods can be coupled 
to either MALDI or ES. However, regards the special attributes of MALDI and ES, 
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MALDI is usually coupled with TOF MS while ES is usually coupled with 
quadrupole and ion-trapping MS. 
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